Form 4: Magnera director granted 5,871 prorated RSUs

Magnera Corp director Thomas Fahnemann received a prorated grant of 5,871 RSUs on November 14, 2025 to align director equity awards with the 2026 Annual Shareholders Meeting timeline.

Summary

• Director Thomas Fahnemann received 5,871 Restricted Stock Units (RSUs) on 2025-11-14 as a prorated portion of the Annual Director Award.
• The RSUs vest in full one year from grant, on 2026-11-14 (one-year cliff vest), and are settled in 5,871 shares of common stock (par value $0.01) upon vesting.
• The grant timing was adjusted to align the director equity schedule with the Annual Shareholders Meeting; this prorated award covers the period between the 2024 RSU lapse reported on 2025-11-04 and the 2026 meeting.
• Price of the derivative security is $0; 5,871 derivative securities (RSUs) are beneficially owned following the transaction; ownership is direct.
• A full 2026 Annual Director Award is expected to be granted at the 2026 Annual Shareholders Meeting upon director reelection.
• The Form 4 was signed by attorney-in-fact Laura A. Jones on 2025-11-18.

Sentiment

Score: 5

Explanation: Routine insider equity grant and timing alignment; neutral impact with minor potential dilution.

Positives

• Aligns director equity grant timing with the Annual Shareholders Meeting, improving governance consistency.
• Clear, single-year vesting structure (vests in full on 2026-11-14) enhances transparency.
• Prorated approach bridges the period between the 2024 RSU lapse (reported 2025-11-04) and the 2026 meeting, avoiding a compensation gap.

Negatives

• Potential dilution of 5,871 shares upon RSU vesting in 2026.
• Award appears purely time-based with no disclosed performance conditions.

Future Outlook

Directors are expected to receive a full 2026 Annual Director Award at the 2026 Annual Shareholders Meeting, contingent upon reelection.

Management Comments

• Director equity schedule is being aligned with the Annual Shareholders Meeting; the 2025 grant is prorated for the period between the 2024 RSU lapse (reported 2025-11-04) and the 2026 meeting.
• The 2025 prorated director award vests in full one year from the grant date.

Industry Context

Time-based RSU grants for non-employee directors that vest after one year and align with the annual shareholder meeting cycle are common among U.S. public companies, reflecting standard corporate governance and compensation practices rather than operational changes.

Comparison to Industry Standards

• Alignment of annual director equity awards with the Annual Shareholders Meeting mirrors practices at large-cap peers (e.g., Microsoft, Apple, JPMorgan), where director equity typically vests over one year and grants are timed around the AGM.
• Prorating equity awards during a change in grant schedule is standard across many S&P 500 companies to avoid over- or under-compensation during transitional periods.
• Use of time-based RSUs (with $0 exercise price) for director compensation is consistent with prevailing U.S. governance norms; no performance conditions for director equity is typical given directors’ oversight role rather than operational accountability.

Corporate Governance

Related Party Transactions

• Equity compensation grant of 5,871 RSUs to director Thomas Fahnemann on 2025-11-14, vesting on 2026-11-14.

Stakeholder Impact

• Shareholders: modest potential dilution of 5,871 shares upon RSU vesting in 2026.
• Directors: clearer alignment of equity compensation with the shareholder meeting cycle.
• Governance observers: increased clarity on timing and structure of director equity awards.

Next Steps

• RSUs vest on 2026-11-14, at which point shares are issued.
• Potential full 2026 Annual Director Award to be considered at the 2026 Annual Shareholders Meeting upon director reelection.

Key Dates

Keywords

Magnera Corp, MAGN, Form 4, restricted stock units, RSU grant, director compensation, insider transaction, vesting, corporate governance, beneficial ownership